๐Ÿ’‰๐Ÿ’ธ Stark difference between big pharma over COVID

๐Ÿ•Š AstraZeneca & Johnson&Johnson will produce their vaccines not for profit during pandemic

๐Ÿ’ต Pfizer now expects $15 BILLION in revenue for its vaccine THIS YEAR

๐Ÿ’ต with profit margin in the high 20s % -could be $4bn profit
๐Ÿ‡บ๐Ÿ‡ธ ๐Ÿ‡ฉ๐Ÿ‡ช Pfizer splits costs and profits with BioNTech

๐Ÿ’‰ Itโ€™s vaccine costs about $20

๐Ÿ’ท AstraZeneca/Oxford vaccine is more like $4

๐ŸŒ that vaccine will be provided to the developing world at cost in perpetuity
๐Ÿคทโ€โ™‚๏ธ You pays your money & you takes your choice-Pfizer vaccine uses new, cutting edge technology & they were first to get approval

Itโ€™s a private company with shareholders & its job is to make money - thatโ€™s how they fund incredibly expensive research & development
๐Ÿค” But is a profit margin like that sustainable year after year if this pandemic persists and we need ongoing vaccination of populations?

Especially with a new administration in the White House, that will face huge pressure
๐Ÿ‡ท๐Ÿ‡บ Some info on Russian Sputnik V jab

๐Ÿ’ต About $10 a dose (2 dose course)
๐Ÿ“ˆ 91.8% effective, inc. older groups
๐Ÿ“ฐ Data now peer reviewed in Lancet
๐Ÿฅถ Store in normal 2-8c refrigeration

๐Ÿ’‰ Vaccinations starting this week in
๐Ÿ‡ง๐Ÿ‡ด ๐Ÿ‡ฐ๐Ÿ‡ฟ ๐Ÿ‡น๐Ÿ‡ฒ ๐Ÿ‡ต๐Ÿ‡ธ ๐Ÿ‡ฆ๐Ÿ‡ช ๐Ÿ‡ต๐Ÿ‡พ ๐Ÿ‡ญ๐Ÿ‡บ ๐Ÿ‡ฆ๐Ÿ‡ฒ ๐Ÿ‡ฉ๐Ÿ‡ฟ ๐Ÿ‡ป๐Ÿ‡ช ๐Ÿ‡ฎ๐Ÿ‡ท

โ€ข โ€ข โ€ข

Missing some Tweet in this thread? You can try to force a refresh
ใ€€

Keep Current with Scott Beasley

Scott Beasley Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @SkyScottBeasley

2 Feb
๐Ÿ’‰ NEW: One dose of AstraZeneca/Oxford vaccine offers 76% protection after day 22 post vaccination - and offers sustained protection through a 3 month period until second dose
New analysis by Oxford University

โ–ถ๏ธ vaccine shows sustained protection of 76% during the 3-month interval until the second dose

โ–ถ๏ธ analyses shows single standard dose efficacy from day 22 to day 90 post vaccination of 76% with protection not falling in this three-month period
โ–ถ๏ธ After the second dose vaccine efficacy from two standard doses is 82.4% with the 3-month interval being used in the UK

โ–ถ๏ธ 82.4% effective, with a 95% confidence interval of 62.7% - 91.7% at 12+ weeks
Read 14 tweets
1 Feb
๐Ÿ’‰ NEW: UK orders 40m more doses of the Valneva Covid vaccine for next year

๐Ÿ“Š It now has total 100m doses on order with options for 90m more doses between 2023-25

Planning for an ongoing, long term vaccination programme being stepped up

๐Ÿ—“ Trial data due in next 3 months
๐Ÿ’‰ ๐Ÿ‡ซ๐Ÿ‡ท French Minister says it will start receiving AstraZeneca vaccine from next week
๐Ÿ“ˆ AstraZeneca is now going to deliver an additional 9m doses to the EU in the first three months of this year

๐Ÿ“Š That should mean a total of 40m doses - and it will start deliveries a week earlier than planned

๐Ÿญ Itโ€™s also going to expand manufacturing capacity in the EU
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!